Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Attorney Paola Pearson Appointed to Plaintiffs' Executive Committee of Elmiron Multi-District Litigation

Paola Pearson, Senior Associate at Philadelphia personal injury law firm Anapol Weiss, has been appointed by the Honorable Judge Brian R. Martinotti of the United States District Court for the District of New Jersey to the Plaintiffs Executive Committee ("PEC") of the recently formed Multi-District Litigation (MDL) for injured consumers alleging products liability claims involving Elmiron, a popular medication used to treat interstitial cystitis and painful bladder syndrome.


News provided by

Anapol Weiss

Jan 28, 2021, 13:00 ET

Share this article

Share toX

Share this article

Share toX


PHILADELPHIA, Jan. 28, 2021 /PRNewswire-PRWeb/ -- Paola Pearson, Senior Associate at Philadelphia personal injury law firm Anapol Weiss, has been appointed by the Honorable Judge Brian R. Martinotti of the United States District Court for the District of New Jersey to the Plaintiffs Executive Committee ("PEC") of the recently formed Multi-District Litigation (MDL) for injured consumers alleging products liability claims involving Elmiron, a popular medication used to treat interstitial cystitis and painful bladder syndrome. Paola joins six other experienced attorneys from across the country to form the Executive Committee leading the litigation against the companies involved in the design, marketing, distribution and sale of Elmiron. Another fourteen experienced attorneys were appointed by Judge Martinotti to serve on the Plaintiffs Steering Committee ("PSC").

"I'm excited to be part of this diverse committee working to bring justice to hundreds of women whose quality of life has been needlessly compromised by this dangerous bladder medication," Paola said of her leadership role. "I have no doubt the collective experience, skill and passion of the group will drive the litigation to a successful outcome while setting a new bar for MDL leadership groups that better represent the changing legal profession."

I have no doubt the collective experience, skill and passion of the group will drive the litigation to a successful outcome while setting a new bar for MDL leadership groups that better represent the changing legal profession.

Post this

Plaintiffs' Committees for mass tort MDLs are selected based on the individual and collective experience and skill and of the attorneys who will steer the litigation and effectively advocate for all plaintiffs.

"Paola Pearson not only talks the talk but walks the walk," said Managing and Name Partner of Anapol Weiss, Sol Weiss, of Paola's appointment. "Whether sifting through major document productions, deposing company employees or medical witnesses, and writing serious briefs, Paola in six years at the bar has mastered Mass Tort litigation. Her appointment to the Elmiron executive committee recognizes her dedication and advocacy."

Multi-District Litigation (MDLs) are created when individual lawsuits for a common product, often allegedly defective pharmaceutical drugs or medical devices, are consolidated in one federal court to streamline the trial preparation process. Elmiron, also known by its chemical name pentosan polysulfate sodium (PPS), has been prescribed to treat interstitial cystitis or chronic bladder pain since 1996. The Elmiron lawsuits (Case No. 2:20-md-02973; MDL No. 2973) seek justice for hundreds of Elmiron patients who have suffered significant vision loss. The Elmiron lawsuits allege hundreds of Elmiron patients have suffered significant vision loss and chronic and permanent damage to cells of the retina due to pigmentary maculopathy. The lawsuit further alleges injuries can range from vision impairment to blindness, which are irreversible and may progress even after patients stop taking the drug.

Paola Pearson has been an Associate at Anapol Weiss for more than six years. Paola earned her Juris Doctorate at the University of Villanova School of Law and is admitted to practice in Pennsylvania and New Jersey as well as the Eastern, Middle and Western Districts of Pennsylvania, the District of New Jersey, the Third Circuit Court of Appeals and the Sixth Circuit Court of Appeals. Paola is a member of the American Association for Justice, the Philadelphia Trial Lawyers Association, the Hispanic Bar Association, the Philadelphia Bar Association and the National Trial Lawyers Top 40 Under 40 Civil Plaintiffs' Attorneys.

About Us
Anapol Weiss is an award-winning Philadelphia personal injury law firm that handles many high-profile nationwide mass torts. The firm was founded over forty years ago, and attorneys of Anapol Weiss are regularly named Best Lawyers and Super Lawyers. To learn more, visit http://www.anapolweiss.com.

Media Contact

Riina Corrigan, Anapol Weiss, +1 (215) 305-7896, [email protected]

Twitter, Facebook

SOURCE Anapol Weiss

Related Links

http://www.anapolweiss.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.